Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer

    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    FP14 - Targeted Therapy - Clinically Focused

    • Type: Posters (Featured)
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 16
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      FP14.16 - Phase 2 Trial of the Alternating Therapy with Osimertinib and Afatinib for Treatment-Naive Patients with EGFR-Mutated Advanced Non–Small Cell Lung Cancer (WJOG10818L/Alt Trial)

      00:00 - 00:00  |  Presenter: Hidetoshi Hayashi

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P76 - Targeted Therapy - Clinically Focused - EGFR

    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 98
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P76.61 - Long Follow up Study of Comparing Erlotinib (ER) with Gefitinib (GE) for Previously Treated Advanced Non-Small Cell Lung Cancer: WJOG5108LFS

      00:00 - 00:00  |  Presenter: Ryo Toyozawa

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P84 - Targeted Therapy - Clinically Focused - ALK

    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 23
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P84.02 - A Phase II Trial of Alectinib-Refractory Non-Small-Cell Lung Cancer with EML4-ALK Fusion Genes; Okayama Lung Cancer Study Group 1405

      00:00 - 00:00  |  Presenter: Toshihide Yokoyama

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.